Skip to main content

Relay Therapeutics, Inc.

RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001812364

In the last 90 days, Relay Therapeutics, Inc. insiders filed 0 open-market purchases and 13 sales; 259 institutions reported holding it in 13F filings for Q2 2026, worth $4.58B in total; Duquesne Family Office is the only superinvestor holding it.

Q4 2024 vs. Q3 2024

How the institutions holding Relay Therapeutics, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of RLAY: Q3 2024 compared with Q4 2024
MeasureQ3 2024Of which not filed for Q4 2024Q4 2024Change
Holders1952200+7
Shares163.4M166.9K163.9M+697.7K (+0.4%)
Value$1.16B$1.18M$675.8M−$479.8M (−41.5%)

2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (44)

Institutions that held Relay Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to RLAY in Q4 2024
InstitutionSharesValue% of portfolio
Kynam Capital Management, LP1,000,000$4.12M0.27%
Balyasny Asset Management LLC692,279$2.85M0.01%
Boxer Capital Management, LLC536,132$2.21M0.19%
Diadema Partners LP505,778$2.08M2.35%
Parkman Healthcare Partners LLC500,548$2.06M0.27%
Schonfeld Strategic Advisors LLC354,500$1.46M0.01%
Susquehanna Fundamental Investments, LLC346,288$1.43M0.02%
BIT Capital GmbH284,508$1.17M0.10%
BNP Paribas Arbitrage, SA239,668$987.4K0.00%
Raymond James Financial Inc189,046$778.9K0.00%
Raiffeisen Bank International AG180,000$752.4K0.01%
Man Group plc173,605$715.3K0.00%
Persistent Asset Partners Ltd145,828$651.9K0.56%
First Trust Advisors LP89,949$370.6K0.00%
Qube Research & Technologies Ltd87,863$362.0K0.00%
Tema ETFs LLC64,655$266.4K0.11%
Aristides Capital LLC43,400$178.8K0.06%
Graham Capital Management, L.P.31,569$130.1K0.00%
Creative Planning29,532$121.7K0.00%
Savant Capital, LLC29,088$119.8K0.00%
Acadian Asset Management LLC28,947$118.0K0.00%
KLP Kapitalforvaltning AS24,700$101.8K0.00%
Police & Firemen's Retirement System of New Jersey23,400$96.4K0.00%
Syon Capital LLC22,157$91.3K0.01%
JustInvest LLC17,525$72.2K0.00%
Atom Investors LP11,765$48.5K0.01%
CIBC World Markets Corp11,388$46.9K0.00%
Twinbeech Capital LP10,204$42.0K0.00%
Stifel Financial Corp10,200$42.0K0.00%
Wingate Wealth Advisors, Inc.5,000$20.6K0.02%
Group One Trading, L.P.4,774$19.7K0.00%
GF Fund Management Co. Ltd.3,515$14.5K0.00%
Skopos Labs, Inc.2,801$11.5K0.00%
R Squared Ltd1,180$4.86K0.00%
SBI Securities Co., Ltd.692$2.85K0.00%
Global Retirement Partners, LLC562$2.31K0.00%
Amundi200$9660.00%
Signaturefd, LLC160$6590.00%
Ancora Advisors, LLC110$4530.00%
True Wealth Design, LLC68$2810.00%
Caitong International Asset Management Co., Ltd63$2600.00%
Comerica Bank35$1440.00%
WealthTrak Capital Management LLC30$1240.00%
IFP Advisors, Inc0$290.00%

Sold out (37)

Institutions that held Relay Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Not filed for Q4 2024 yet (2)

Institutions that held Relay Therapeutics, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RLAY in Q3 2024 that haven't filed for Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Raymond James Financial Services Advisors, Inc.100,073$708.5K
Raymond James & Associates66,842$473.2K